Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stopstudy estradiol discontinuation and restart study in older transgender women
NL-OMON58693Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol valerate in Gender incongruence (GI), sponsored by Amsterdam University Medical Center. Primary endpoint: Cardiovascular risk determinants. Started Feb 2024; status: completed.
02
Drugs
estradiol valerate
03
Conditions
Gender incongruence (GI)
Beyond the preview
Go deeper on NL-OMON58693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58693.